Product Portfolio Change at P&G

Interesting to see that Proctor and Gamble must have been considering their business portfolio, they are selling their pharmaceutical business to the Irish drugmaker Warner Chilcott – see story here

This is a classic example of an organisation considering the future, presumably based on the factors typically included in the various portfolio matrices which are considered in the CIM qualifications from Certificate through to Postgraduate Diploma, the main reason cited in the story being the level of competition from generic drugs. This indicates that P&G feel their competitive strength lie elsewhere so they will be concentrating their efforts on other business activities.

The official news release from P&G and Warner Chilcott can be seen here or here